1-4 of 4
myelosuppression
Close
Sort by
Journal Articles

Therapy for myeloproliferative neoplasms: when, which agent, and how?

Holly L. Geyer, Ruben A. Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 277–286.
https://doi.org/10.1182/asheducation-2014.1.277
Published: 2014
Journal Articles

JAK inhibition in the myeloproliferative neoplasms: lessons learned from the bench and bedside

Jason Gotlib
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 529–537.
https://doi.org/10.1182/asheducation-2013.1.529
Published: 2013
Journal Articles

Targeting B-cell receptor signaling: changing the paradigm

Nathan Fowler, Eric Davis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 553–560.
https://doi.org/10.1182/asheducation-2013.1.553
Published: 2013
Journal Articles

Therapeutic potential of JAK2 inhibitors

Srdan Verstovsek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 636–642.
https://doi.org/10.1182/asheducation-2009.1.636
Published: 2009